Yu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, Ying-Chun Shen, Chih-Hung Hsu and Ann-Lii Cheng Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma Cancer 116
Article first published online: 19 AUG 2010 | DOI: 10.1002/cncr.25257
Antiangiogenic therapy is the current standard therapy for patients with advanced hepatocellular carcinoma. In this study, the authors demonstrated that an early alpha-fetoprotein response predicted better response and disease-control rates and longer progression-free and overall survival in these patients.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field